Recombinant DNA as a paradigm of a new technology: its impact on regulation by the Food and Drug Administration
Miller, H.I.
Journal of Parenteral Science and Technology a Publication of the Parenteral Drug Association 36(6): 248-250
1982
ISSN/ISBN: 0279-7976 PMID: 7161656 Document Number: 193761
Document emailed within 1 workday
Related Documents
Garfin, S.R.; Yuan, H.A. 1997: Food and Drug Administration regulation of spinal implant fixation devices Clinical Orthopaedics and Related Research 335: 32-38Korwek, E.L. 1981: OSHA regulation of industrial applications of recombinant DNA technology University of Cincinnati Law Review. University of Cincinnati. College of Law 50(2): 284-313
Chopra, J.G. 1979: The role of Food and Drug Administration in food allergy Annals of Allergy 42(1): 1-4
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Fineberg, H.V. 2007: Reinventing the US Food and Drug Administration Medgenmed: Medscape General Medicine 9(2): 6
Smart, T. 1996: Delavirdine dilemma at the FDA. Food and Drug Administration Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 10(12): 4-5
Minno, A.M. 1972: A physicians's viewpoint. The Food and Drug Administration Pennsylvania Medicine 75(7): 61-62
Henney 2000: From the food and drug administration: new inhaled corticosteroid JAMA 284(13): 1640
1991: Pre-approval inspections/investigations. Food and Drug Administration Journal of parenteral science and technology: a publication of the Parenteral Drug Association 45(1): 56-66
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Mallory, D. 1991: International experts met at the United States Food and Drug Administration Immunohematology 7(2): 52
Henney 2000: From the food and drug administration: shock wave for heel pain JAMA 284(21): 2711
Yin, L. 1976: The role of the Food and Drug Administration in instrumentation today and in the future Journal of Reproductive Medicine 16(4): 184-186
Schwetz, B.A. 2001: U.S. Food and Drug Administration--a science-based regulatory agency Journal - Association of Official Analytical Chemists 84(1): 171-175
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Nightingale, S.L. 1989: From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma JAMA 261(3): 350
Steinbrook, R. 2017: Disclosing the Conflicts of Interest of US Food and Drug Administration Advisory Committee Members JAMA Internal Medicine 177(7): 919
Frederiksen, N.L. 1995: Guidelines for prescribing dental radiographs. United States Food and Drug Administration Texas Dental Journal 112(2): 63-67
Baker, R. 1995: FDA approves baboon bone marrow transplant for AIDS patient. Food and Drug Administration Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 1995: 7-8
Pennington, J.A.; Capar, S.G.; Parfitt, C.H.; Edwards, C.W. 1996: History of the Food and Drug Administration's Total Diet Study (Part II), 1987-1993 Journal - Association of Official Analytical Chemists 79(1): 163-170